INFLUENCE OF HLA, ABO, AND Rh(D) ON SURVIVAL AFTER REMISSION IN ACUTE MYELOGENOUS LEUKÆMIA
- 24 September 1977
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 310 (8039) , 653
- https://doi.org/10.1016/s0140-6736(77)92515-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- HLA linked resistance factors and survival in acute myelogenous leukemiaCancer, 1977
- TREATMENT OF CUSHING'S DISEASE WITH CYPROHEPTADINEThe Lancet, 1977
- CUSHING'S DISEASE: SUCCESSFUL TREATMENT WITH CYPROHEPTADINEThe Lancet, 1977
- Bromocriptine for Cushing's disease.BMJ, 1977
- BROMOCRIPTINE IN NELSON'S SYNDROME AND CUSHING'S DISEASEThe Lancet, 1976
- CYPROHEPTADINE IN NELSON'S SYNDROMEThe Lancet, 1976
- Modification of Adrenal Function by the Anti-Serotonin Agent CyproheptadineJournal of Clinical Endocrinology & Metabolism, 1976
- Cyproheptadine-Induced Remission of Cushing's DiseaseNew England Journal of Medicine, 1975
- Inhibition of ACTH Response to Oral and Intravenous Metyrapone by Antiserotoninergic Treatment in ManJournal of Clinical Endocrinology & Metabolism, 1975
- Genetic Control Of Murine Viral LeukemogenesisAdvances in Cancer Research, 1973